Galecto, Inc. GLTO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

53/100

3/6 Pass

SharesGrow Intrinsic Value

Galecto, Inc. (GLTO) has 19 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est Hewes L. Becker avec 264,629 actions. Parmi les autres détenteurs notables Sattarzadeh Sherwin et Pedersen Anders.

Au cours des 12 derniers mois, les initiés ont effectué 21 transactions sur GLTO l'action — 8 achats (d'une valeur de $16.23K) et 2 ventes (d'une valeur de $1.38K). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.

GLTO Participations des Initiés

Principal Actionnaire

Hewes L. Becker

264,629 actions

Achats (12 mois)

$16.23K valeur

Ventes (12 mois)

$1.38K valeur

Activité de transactions (12 mois)

Acheter 38%

Vendre 10%

Principaux actionnaires initiés

#	Nom	Rôle	Actions détenues	Dernière déclaration	Taille relative
1	Hewes L. Becker	Chief Medical Officer	264,629	2026-01-07	100%
2	Sattarzadeh Sherwin	Chief Operating Officer	190,376	2026-01-26	72%
3	Pedersen Anders	Chief Operating Officer	115,000	2023-01-05	43%
4	Lindmark Bertil	Chief Medical Officer	115,000	2023-01-05	43%
5	Freve Jonathan	Chief Financial Officer	100,000	2024-01-05	38%
6	Orbimed Advisors Llc	10 Percent Owner	97,204	2023-08-17	37%
7	Oestreich Stephanie	Chief Business Officer	80,000	2023-01-05	30%
8	Khuong Chau Quang	Director	18,000	2023-06-15	7%
9	Kronmiller Matthew	EVP Strategy and Cbo	6,000	2025-01-07	2%
10	Schambye Hans T.	Chief Executive Officer	2,640	2026-01-06	1%
11	Goldfischer Carl	Director	1,440	2025-06-20	1%
12	Winslow Garrett	General Counsel	1,320	2026-01-06	0%
13	Firmani Lori	Chief Financial Officer	726	2026-01-06	0%
14	Wechsler Amy B	Director	720	2025-06-20	0%
15	Munshi Amit	Director	720	2025-06-20	0%
16	Shapiro David	Director	720	2025-06-20	0%
17	Dallas Jayson Donald Alexander	Director	720	2025-06-20	0%
18	Prener Anne	Director	720	2025-06-20	0%
19	Fairmount Funds Management Llc	10 Percent Owner	574	2026-02-12	0%

Transactions récentes (12 derniers mois)

Date	Nom	Rôle	Type	Actions	Prix	Valeur
2026-02-09	Bruno Julianne	Director	Exercice d'Options (Vente)	129	-	-
2026-02-09	Fairmount Funds Management Llc	10 Percent Owner	Exercice d'Options (Vente)	2,904	-	-
2026-01-05	Sattarzadeh Sherwin	Chief Operating Officer	Attribution de RSU	190,376	-	-
2026-01-05	Sattarzadeh Sherwin	Officer	Inconnu	-	-	-
2026-01-05	Hewes L. Becker	Chief Medical Officer	Attribution de RSU	264,629	-	-
2026-01-05	Hewes L. Becker	Officer	Inconnu	-	-	-
2026-01-02	Schambye Hans T.	Chief Executive Officer	Exercice d'Options (Vente)	1,360	-	-
2026-01-02	Firmani Lori	Chief Financial Officer	Exercice d'Options (Vente)	374	-	-
2026-01-02	Winslow Garrett	General Counsel	Exercice d'Options (Vente)	680	-	-
2025-11-10	Bruno Julianne	Director	Inconnu	129,000	-	-
2025-11-10	Cain Christopher W.	Officer	Inconnu	-	-	-
2025-11-10	Fairmount Funds Management Llc	10 Percent Owner	Inconnu	16,366,000	-	-
2025-07-03	Schambye Hans T.	Chief Executive Officer	Exercice d'Options (Vente)	1,360	-	-
2025-07-03	Firmani Lori	Interim CFO	Vente Informative	147	$3.39	$498.33
2025-07-03	Winslow Garrett	General Counsel	Vente Informative	260	$3.39	$881.40
2025-06-18	Prener Anne	Director	Attribution de RSU	720	$3.22	$2.32K
2025-06-18	Wechsler Amy B	Director	Attribution de RSU	720	$3.22	$2.32K
2025-06-18	Dallas Jayson Donald Alexander	Director	Attribution de RSU	720	$3.22	$2.32K
2025-06-18	Munshi Amit	Director	Attribution de RSU	720	$3.22	$2.32K
2025-06-18	Shapiro David	Director	Attribution de RSU	720	$3.22	$2.32K
2025-06-18	Goldfischer Carl	Director	Attribution de RSU	1,440	$3.22	$4.64K